🔗 Share this article Users Stopping Slimming Jabs Regain Pounds at a Quadrupled Rate Than Dieters Obesity treatment involves ongoing approaches. A recent study indicates that patients who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro tend to recover lost weight far faster than those who stop conventional diet and exercise programs. Published data in a major medical journal points out that while overweight individuals often shed a large proportion of their body weight while on the medication, the mass is regained at an estimated rate of 0.8 kg per month once they quit. "People purchasing these drugs must be cognizant of the risk of fast weight regain when the treatment concludes," warns expert Dr. Susan Jebb. That rate of recovery implies a reversion to pre-treatment mass within about a year and a half. Weighing Treatments The study, which reviewed dozens of trials involving thousands of participants, compared the results of these new drugs with older methods. Researchers emphasize that individuals who shed pounds through diet and exercise generally experience a less rapid creep back—around 0.1 kg a month—post-intervention. Understanding the Fast Regain Experts believe the mode of action of the injections is key to understanding the amplified weight return. These medications copy a natural hormone called glucagon-like peptide-1, which controls hunger. "Sustained high doses of GLP-1 concentrations several times higher than the body's typical production may cause the system to produce less of its endogenous GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher. "Discontinuation of this medication means appetite is uncontrolled, making binge eating far more likely." An Ongoing Issue? The NHS recommend the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications. A number of clinicians argue that, considering the likelihood of relapse, the treatment is often life-long. This perspective is supported by pharmaceutical companies, who say that the findings "highlight the persistent character of obesity," comparing it to managing conditions like diabetes. Patient Testimonies Individuals who have discontinued the medication explain a intense resurgence of cravings. "It was like a trigger activating and you become ravenous," said an individual. The struggle is worsened if patients have not adopted permanent lifestyle or habit changes during therapy. Growing Interest Recent estimates indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with interest remaining high. Use is more common among females than men. The middle-aged demographic shows the highest usage rates. A large proportion access the medications through private healthcare rather than public health services. Ultimately, experts caution that while these medications are potent agents for shedding pounds, they are not a magic fix and maintained weight loss relies on combined behavioural management.
Obesity treatment involves ongoing approaches. A recent study indicates that patients who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro tend to recover lost weight far faster than those who stop conventional diet and exercise programs. Published data in a major medical journal points out that while overweight individuals often shed a large proportion of their body weight while on the medication, the mass is regained at an estimated rate of 0.8 kg per month once they quit. "People purchasing these drugs must be cognizant of the risk of fast weight regain when the treatment concludes," warns expert Dr. Susan Jebb. That rate of recovery implies a reversion to pre-treatment mass within about a year and a half. Weighing Treatments The study, which reviewed dozens of trials involving thousands of participants, compared the results of these new drugs with older methods. Researchers emphasize that individuals who shed pounds through diet and exercise generally experience a less rapid creep back—around 0.1 kg a month—post-intervention. Understanding the Fast Regain Experts believe the mode of action of the injections is key to understanding the amplified weight return. These medications copy a natural hormone called glucagon-like peptide-1, which controls hunger. "Sustained high doses of GLP-1 concentrations several times higher than the body's typical production may cause the system to produce less of its endogenous GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher. "Discontinuation of this medication means appetite is uncontrolled, making binge eating far more likely." An Ongoing Issue? The NHS recommend the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications. A number of clinicians argue that, considering the likelihood of relapse, the treatment is often life-long. This perspective is supported by pharmaceutical companies, who say that the findings "highlight the persistent character of obesity," comparing it to managing conditions like diabetes. Patient Testimonies Individuals who have discontinued the medication explain a intense resurgence of cravings. "It was like a trigger activating and you become ravenous," said an individual. The struggle is worsened if patients have not adopted permanent lifestyle or habit changes during therapy. Growing Interest Recent estimates indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with interest remaining high. Use is more common among females than men. The middle-aged demographic shows the highest usage rates. A large proportion access the medications through private healthcare rather than public health services. Ultimately, experts caution that while these medications are potent agents for shedding pounds, they are not a magic fix and maintained weight loss relies on combined behavioural management.